Search Results
Slidesets
Probing the Microbiome in Disease: From CRC to HIV - Cynthia Sears, MD
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
Slidesets
Navigating NASH biomarkers: From discovery to clinical practice- John Sninsky, PhD
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
The "Why, When and How To" of HIV Disclosure: Perspectives from the North and South - Ann Petru
Presented at:
International Workshop on HIV Pediatrics 2020
Slidesets
Perspective from health economics - David Rein, PhD
Presented at:
International Hepatitis Cure & Eradication Meeting 2015
E-Posters
Combined Use Of High-Sensitivity Serological And Virological Hbv Markers Can Make Better In Predicting The Occurrence Of HBV Reactivation And To Optimize Prophylaxis Duration In HBsAg-Negative/Anti-HBc-Positive Patients In The Context Of Oncohematological
M. Alkhatib
Presented at:
European Meeting on HIV & Hepatitis 2020
Slidesets
Perspective from Medical Community - Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD
Presented at:
International Hepatitis Cure & Eradication Meeting 2015
Slidesets
Round Table Discussion: True demand from the communities- Midnigh Poonkasetwattana
Presented at:
APACC 2017
Slidesets
Self-Testing for HCV: Lessons Learned from Implementation Pilots | Sonjelle Shilton
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2023
Slidesets
Transitioning from International to Domestic Funding: Experiences in the Asia Pacific- Ravipa Vannakit, RN, MSc
Presented at:
APACC 2019
Videos
Experience from Ethiopia - Mulat Nigus, MPH
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021